Contact Information:

Office: C424 GH
Phone: 356-4187
Faculty Profile

Brief description of current research: 

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in Western Countries and comprises a range of conditions varying in severity. Although widely studied in persons with type 2 diabetes (T2D), far less is known about NAFLD in type 1 diabetes (T1D). Liver dysfunction in NAFLD drives insulin resistance and is associated with increased severity of diabetic complications. Defining pathways of NAFLD development and progression in Type 1 and Type 2 diabetes patients using metabolomic analysis is critical to our understanding and treatment of this common metabolic disease. My current pilot study involves using metabolomics and Fibroscan to investigate NAFLD in Type 1 Diabetes.

3 most influential diabetes/obesity/metabolism publications:

• Fischmann Magee M, A Taiwo A, Howard BV. Management of Diabetes with Coronary Artery Disease. Curr Treat Options Cardiovasc Med. 2003 Feb;5(1):75-88. doi: 10.1007/s11936-003-0016-x. PMID: 12686020.
• Yangbo S, MD PhD, Buyun L. Jessica K MD, Correia M, MD PhD, Jones DL DNP, Zhu Z MD, Taiwo A, et al. Association of preoperative body weight and weight loss with risk of death after bariatric surgery. JAMA Network Open 2020;3(5):e204803. doi:10.1001/jamanetworkopen.2020.4803

Quote: 

Never underestimate the power of an inquisitive mind to propel science” – (Adeyinka Taiwo)